Profil
Pierre Brégeard formerly worked at Stentys SA, as Chief Technology Officer from 2017 to 2020.
Mr. Brégeard received his graduate degree from Université de Lorraine.
Ehemalige bekannte Positionen von Pierre Brégeard
| Unternehmen | Position | Ende |
|---|---|---|
| STENTYS | Chief Tech/Sci/R&D Officer | 01.01.2020 |
Ausbildung von Pierre Brégeard
| Université de Lorraine | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
